New weekly shot aims to tame type 1 diabetes
NCT ID NCT06820281
Summary
This study is testing if a weekly injection called tirzepatide can help the body use insulin better and control blood sugar in people with type 1 diabetes. It will involve 44 adults who will receive either the real injection or a placebo for 6 weeks. Researchers will measure changes in insulin sensitivity, hormone levels, and blood sugar control to see if the treatment offers benefits beyond weight loss.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Garvan Institute of Medical Research
Sydney, New South Wales, 2010, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.